A Phase II Study of Neoadjuvant PLD/Cyclophosphamide and Sequential nab-Paclitaxel Plus Dual HER2 Blockade in HER2-Positive Breast Cancer
Article in The Oncologist (June 2023)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Article in The Oncologist (June 2023)
Article in Biomolecules (June 2022)
Article in Pharmaceutics (November 2021)